BioCardia
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioCardia and other ETFs, options, and stocks.About BCDA
BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and Avance Steerable Introducers.
CEOPeter Alan Altman
CEOPeter Alan Altman
Employees20
Employees20
HeadquartersSunnyvale, California
HeadquartersSunnyvale, California
Founded1994
Founded1994
Employees20
Employees20
BCDA Key Statistics
Market cap12.42M
Market cap12.42M
Price-Earnings ratio-0.68
Price-Earnings ratio-0.68
Dividend yield—
Dividend yield—
Average volume121.22K
Average volume121.22K
High today$1.25
High today$1.25
Low today$1.16
Low today$1.16
Open price$1.23
Open price$1.23
Volume98.75K
Volume98.75K
52 Week high$3.20
52 Week high$3.20
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
BioCardia(BCDA) stock is priced at $1.19, giving the company a market capitalization of 12.42M. It carries a P/E multiple of -0.68.
During the trading session on 2025-12-31, BioCardia(BCDA) shares reached a daily high of $1.25 and a low of $1.16. At a current price of $1.19, the stock is +2.4% higher than the low and still -4.8% under the high.
Trading volume for BioCardia(BCDA) stock has reached 98.75K, versus its average volume of 121.22K.
The stock's 52-week range extends from a low of $1.00 to a high of $3.20.
The stock's 52-week range extends from a low of $1.00 to a high of $3.20.
People also own
Based on the portfolios of people who own BCDA. This list is generated using Robinhood data, and it’s not a recommendation.